<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title><![CDATA[Shane Pearse]]></title>
<link>/profile/shane-pearse/spearse003/rss20/</link>
<description><![CDATA[Pharmaceutical marketing research expert. In addition to researching medications across virtually all therapeutic areas, has worked in areas such as sales force targeting and access, DTC advertising, wound care, hospital supplies and medical equipment, use of IT, software and online tools.]]></description>
<item>
<title><![CDATA[Are You Using Word Clouds?]]></title>
<link>http://www.greenbookblog.org/2011/12/07/are-you-using-word-clouds/</link>
<guid isPermaLink="false">http://www.greenbookblog.org/2011/12/07/are-you-using-word-clouds/</guid>
<pubDate>Wed, 07 Dec 2011 17:09:46 EST</pubDate>
<description><![CDATA[I think there are serious pressures on both supplier and client side that work against crafting a careful, visually compelling final narrative and presentation - cost and deadlines for example. But going the extra visual yard is actually extremely valuable, as it's often the only part of the iceberg that internal clients and other influencing stakeholders see.]]></description>
</item>
<item>
<title><![CDATA[Our High-Tech Health-Care Future]]></title>
<link>http://www.nytimes.com/2011/11/10/opinion/our-high-tech-health-care-future.html</link>
<guid isPermaLink="false">http://www.nytimes.com/2011/11/10/opinion/our-high-tech-health-care-future.html</guid>
<pubDate>Thu, 10 Nov 2011 20:22:59 EST</pubDate>
<description><![CDATA[The United States should commit to a &quot;moon shot&quot; for a consumer health revolution.]]></description>
</item>
<item>
<title><![CDATA[Analysis: Lipitor, legendary cash cow, prepares for fadeout | Reuters]]></title>
<link>http://www.reuters.com/article/2011/11/06/us-lipitor-idUSTRE7A51R520111106</link>
<guid isPermaLink="false">http://www.reuters.com/article/2011/11/06/us-lipitor-idUSTRE7A51R520111106</guid>
<pubDate>Thu, 10 Nov 2011 17:30:41 EST</pubDate>
<description><![CDATA[NEW YORK (Reuters) - It may take a breakthrough treatment for Alzheimer's disease to match the $130 billion lifetime sales record of Pfizer's Lipitor, the cholesterol fighter that wrote its own chapter]]></description>
</item>
</channel>
</rss>